Successful Control of Acute Myelofibrosis with Lenalidomide
2010

Successful Control of Acute Myelofibrosis with Lenalidomide

publication Evidence: low

Author Information

Author(s): G. Vassilopoulos, M. Palassopoulou, K. Zisaki, M. Befani, E. Bouronikou, N. Giannakoulas, E. Stathopoulou, P. Matsouka

Primary Institution: University Hospital of Larisa

Hypothesis

Can lenalidomide effectively treat acute myelofibrosis?

Conclusion

Lenalidomide treatment led to normalization of blood counts and reduced the need for growth factor support in a patient with acute myelofibrosis.

Supporting Evidence

  • The patient was transfusion-independent after 6 months of lenalidomide treatment.
  • Bone marrow biopsies showed improvement in fibrosis and cellularity after treatment.
  • Lenalidomide is known for its immunomodulatory effects, which may have contributed to the patient's recovery.

Takeaway

A woman with a rare blood disease got better after taking a medicine called lenalidomide, which helped her blood counts return to normal.

Methodology

The patient was treated with lenalidomide for 21 days along with growth factor support after failing other treatments.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

59-year-old female patient.

Digital Object Identifier (DOI)

10.1155/2010/421239

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication